by rss feed | May 20, 2026 | ASGCT 2026, FDA, FDA patient voices, Meetings, Megha Kaushal, News Feeds, PFDD
I’ve been thinking more about the interplay between patient voices and FDA oversight of emerging cell and gene therapies. How do we find integration and balance here? In line with this topic, the FDA’s Megha Kaushal, MD spoke last week in Boston at ASGCT...
